Next Article in Journal
Cytokine and Chemokine Responses in Invasive Aspergillosis Following Hematopoietic Stem Cell Transplantation: Past Evidence for Future Therapy of Aspergillosis
Next Article in Special Issue
Structural Insight into a Yeast Maltase—The BaAG2 from Blastobotrys adeninivorans with Transglycosylating Activity
Previous Article in Journal
Effect of a Wood-Based Carrier of Trichoderma atroviride SC1 on the Microorganisms of the Soil
Previous Article in Special Issue
Proline-Specific Fungal Peptidases: Genomic Analysis and Identification of Secreted DPP4 in Alkaliphilic and Alkalitolerant Fungi
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases

1
Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Universitätsplatz 1, 01968 Senftenberg, Germany
2
Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses, Am Mühlenberg 13, 14476 Potsdam-Golm, Germany
3
Chiracon GmbH, Im Biotechnologiepark 9, 14943 Luckenwalde, Germany
4
Department of Bio- and Environmental Sciences, TU Dresden-International Institute Zittau, Markt 23, 02763 Zittau, Germany
*
Author to whom correspondence should be addressed.
J. Fungi 2021, 7(9), 752; https://doi.org/10.3390/jof7090752
Submission received: 27 August 2021 / Revised: 10 September 2021 / Accepted: 10 September 2021 / Published: 13 September 2021
(This article belongs to the Special Issue Fungal Enzymes 2021)

Abstract

Antithrombotic thienopyridines, such as clopidogrel and prasugrel, are prodrugs that undergo a metabolic two-step bioactivation for their pharmacological efficacy. In the first step, a thiolactone is formed, which is then converted by cytochrome P450-dependent oxidation via sulfenic acids to the active thiol metabolites. These metabolites are the active compounds that inhibit the platelet P2Y12 receptor and thereby prevent atherothrombotic events. Thus far, described biocatalytic and chemical synthesis approaches to obtain active thienopyridine metabolites are rather complex and suffer from low yields. In the present study, several unspecific peroxygenases (UPOs, EC 1.11.2.1) known to efficiently mimic P450 reactions in vitro—but requiring only hydroperoxide as oxidant—were tested for biocatalytic one-pot syntheses. In the course of the reaction optimization, various parameters such as pH and reductant, as well as organic solvent and amount were varied. The best results for the conversion of 1 mM thienopyridine were achieved using 2 U mL−1 of a UPO from agaric fungus Marasmius rotula (MroUPO) in a phosphate-buffered system (pH 7) containing 5 mM ascorbate, 2 mM h−1 H2O2 and 20% acetone. The preparation of the active metabolite of clopidogrel was successful via a two-step oxidation with an overall yield of 25%. In the case of prasugrel, a cascade of porcine liver esterase (PLE) and MroUPO was applied, resulting in a yield of 44%. The two metabolites were isolated with high purity, and their structures were confirmed by MS and MS2 spectrometry as well as NMR spectroscopy. The findings broaden the scope of UPO applications again and demonstrate that they can be effectively used for the selective synthesis of metabolites and late-state diversification of organic molecules, circumventing complex multistage chemical syntheses and providing sufficient material for structural elucidation, reference material, or cellular assays.
Keywords: thienopyridine; clopidogrel; prasugrel; unspecific peroxygenase; human drug metabolites; antiplatelet thienopyridine; clopidogrel; prasugrel; unspecific peroxygenase; human drug metabolites; antiplatelet
Graphical Abstract

Share and Cite

MDPI and ACS Style

Kiebist, J.; Schmidtke, K.-U.; Schramm, M.; König, R.; Quint, S.; Kohlmann, J.; Zuhse, R.; Ullrich, R.; Hofrichter, M.; Scheibner, K. Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases. J. Fungi 2021, 7, 752. https://doi.org/10.3390/jof7090752

AMA Style

Kiebist J, Schmidtke K-U, Schramm M, König R, Quint S, Kohlmann J, Zuhse R, Ullrich R, Hofrichter M, Scheibner K. Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases. Journal of Fungi. 2021; 7(9):752. https://doi.org/10.3390/jof7090752

Chicago/Turabian Style

Kiebist, Jan, Kai-Uwe Schmidtke, Marina Schramm, Rosalie König, Stephan Quint, Johannes Kohlmann, Ralf Zuhse, René Ullrich, Martin Hofrichter, and Katrin Scheibner. 2021. "Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases" Journal of Fungi 7, no. 9: 752. https://doi.org/10.3390/jof7090752

APA Style

Kiebist, J., Schmidtke, K.-U., Schramm, M., König, R., Quint, S., Kohlmann, J., Zuhse, R., Ullrich, R., Hofrichter, M., & Scheibner, K. (2021). Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases. Journal of Fungi, 7(9), 752. https://doi.org/10.3390/jof7090752

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop